- News article -

Customer success-story: Optomed secured 1,97 M€ EU funding for Smartscope-X – affordable, accessible and automatic screening for diabetic retinopathy

12 Oct 2017

In May, the Finnish medical technology company Optomed was granted 1,97 M€ from Horizon 2020 SME Phase 2 instrument under the topic Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well. The funding will help Optomed make their product Smartscope-X the leading solution for diabetic retinopathy screening, supporting the company’s vision to provide affordable eye screenings to everyone.

Diabetic retinopathy is the most frequent cause of preventable blindness in working-aged adults, affecting people with all types of diabetes. Visual impairment and blindness caused by diabetic retinopathy can be prevented through early and effective screening. Currently, screening is costly, time-consuming and needs to be done by an ophthalmologist. Optomed’s solution will allow patients to do the screenings automatically and get the diagnosis in real-time.

Optomed’s fully automated diabetic retinopathy screening solution consists of three main components: a low-cost handheld camera, an automated screening algorithm and a cloud service for eyeground images. As a low-cost and portable solution, Smartscope-X can also provide access to screening for example in developing countries.

Spinverse supported Optomed in project preparation, including help in defining the scope, matching the call and assisting in writing the proposal. After a positive decision from the EU Commission in May 2017, Spinverse supported Optomed in the project negotiation phase.

“The cooperation with Spinverse worked well. The applicant always has the main responsibility during the application process, but the support from Spinverse and their expertise on the application process helped us achieve the desired outcome,” says Seppo Kopsala, CEO of Optomed.

The project officially began in August. Currently, Optomed is working on product development related to the integration between the camera and the software as well as choosing subcontractors for the server solution. Next steps towards the commercialization of Smartscope-X include several clinical tests and commercial pilots in target countries during 2018–2019.

What can you achieve with EU funding? See how we have helped companies create success stories and  contact us to discuss your options.

Photo credit: Optomed

- News -

Relevant posts

Innovation Challenge SME Spinverse News

Innovation Challenge as a springboard to success

17 Jul 2019

While Spinverse Innovation Challenge allows the large companies looking for new ideas to find truly out-of-t...

EU project Spinverse News

Spinverse enhancing business potential of European pulp mills and biorefineries

2 Jul 2019

Spinverse facilitated forming a four-year EU funded project for developing 100% bio-based chemicals, produce...

CTO of the Year ctoeurope Spinverse News

Putting EU innovation centre stage: Orgalim partners with CTO of the Year Europe award

27 Jun 2019

Orgalim, the association representing Europe’s technology industries, has become a partner to the CTO (Chi...

Spinverse News

Can Finland return to the top in economic competitiveness?

20 Jun 2019

In its new programme, the Finnish Government says that it is committed to making Finland more competitive. T...

EU funding Horizon 2020 Spinverse News

2 million euros of EU funding to ManoMotion’s groundbreaking mobile AR technology

19 Jun 2019

Swedish ManoMotion succeeded in receiving extremely competed Horizon 2020 funding in the first try with Spin...

EU funding SME Spinverse News

Taking you to the frontier: the popular funding scheme for SMEs revamped

17 Jun 2019

European Commission shifts into high gear in its popular funding scheme for small and medium-sized enterpris...